newsfilter
← Latest News
ACCESS Newswire·

Hemogenyx Pharmaceuticals PLC Announces Half-year Report

Half-year ReportInterim Results for the period ended 30 June 2022 LONDON, UK / ACCESSWIRE / September 29, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the Standard Listed biopharmaceutical group developing therapies designed to transform blood disea